JDD December 2023 Issue Highlights
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl …
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl … 
JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Eva Kerby, assistant professor of clinical dermatology at Weill Cornell Medical College. Dr. Kerby shares her preferred medical treatment options for keloids, and why it’s important to set treatment expectations with patients. Watch as Dr. Kerby shares tips for good injection technique and how to treat larger, nodul … 
Keratoacanthomas are a low-grade, well-differentiated variant of squamous cell carcinoma. Characteristically, their abrupt-onset and crateriform microscopic findings assist with their differentiation from more aggressive squamous cell carcinoma. While surgical treatment remains a viable and appropriate option for their management, clinical scenarios (described below) may portend to better outcomes … 
Some of the most rewarding patients to help in dermatology are those who struggle with keloids and scars. The field remains an area of active research, and we are continually learning about the pathogenesis and optimal treatment modalities of scars. On Day 1 of the 2021 Skin of Color Update virtual conference, we were fortunate to hear from Dr. Jill Waibel MD, a world-recognized leader and innovat … 